David Wai Meng Tai

Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition

Raghav Sundar, Kie Kyon Huang, Vikrant Kumar et al. · Gut · 2021 · 39 citations · Full text

Inferring cancer disease response from radiology reports using large language models with data augmentation and prompting

Ryan Tan, Qian Lin, Guat Hwa Low et al. · Journal of the American Medical Informatics Association · 2023 · 37 citations · Full text

Metabolomic prediction of treatment outcome in pancreatic ductal adenocarcinoma patients receiving gemcitabine

Lee Cheng Phua, Shixu Goh, David Wai Meng Tai et al. · Cancer Chemotherapy and Pharmacology · 2017 · 29 citations

Treatment Outcome, Pancreatic Cancer, Medicine +8

Rare Incidence of <i>ROS1</i> Rearrangement in Cholangiocarcinoma

Sun Min Lim, Jeong Eun Yoo, Kiat Hon Lim et al. · Cancer Research and Treatment · 2016 · 19 citations · Full text

Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies

Jing Han Hong, Chern Han Yong, Hong Lee Heng et al. · Gut · 2023 · 18 citations